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Objective: This study evaluated the effect of Low Level Laser Therapy (LLLT) and Mesenchymal Stem Cells
(MSCs) on bone regeneration.
Background data: Although several studies evaluated the effects of MSCs and LLLT, there is little informa-
tion available regarding in vivo application of LLLT in conjunction with MSCs.
Methods: Forty-eight circular bone defects (6 mm in diameter) were prepared in the calvaria of 12 New-
Zealand white rabbits. The defects of each animal were randomly assigned to 4 groups: (C) no treatment;
(L) applying LLLT; (SC) filled with MSCs; (SCL) application of both MSCs and LLLT. LLL was applied on
alternate days at wavelength of 810 nm, power density of 0.2 W/cm2 and a fluency of 4 J/cm2 using a
Gallium–Aluminum–Arsenide (GaAlAs) diode laser. The animals were sacrificed after 3 weeks and then
histological samples were evaluated to determine the amount of new bone formation and the remaining
scaffold and inflammation.
Results: The histological evaluation showed a statistically significant increase in new bone formation of
LLLT group relative to the control and the other two experimental groups (p < 0.05). There was no signif-
icant difference in bone formation of the control group compared to experimental groups filled with
MSCs. Laser irradiation had no significant effect on resorption of the scaffold material. In addition, inflam-
mation was significantly reduced in LLLT group compared to the control defects and the other two exper-
imental groups.
Conclusion: Low level laser therapy could be effective in bone regeneration but there is no evidence of a
synergistic effect when applied in conjunction with MSCs.
 2015 Elsevier B.V. All rights reserved.1. Introduction
Bone defects are not always straightforward to repair [1]. A
variety of methods have been developed to enhance bone repair
including autogenous bone grafts or synthetic materials used to fillup the defects [1,2]. Up until recently, the use of autologous grafts
has been considered as the gold standard of treatment for bone
regeneration [1]. However, its implementation has been restricted
due to difficulties in the procedure of obtaining autogenous bone,
including inadequate bone supply, donor site pain, infection,
remaining scar and risk of nerve injury [1,2]. Other types of bone
materials including demineralized bone matrix, Hydroxyapatite,
Tricalcium phosphate, etc., are not as effective as the autogenous
bone due to lower osteo-inductive capacity [3,4]. Efforts to over-
come the problem led to the development of tissue engineered
bone regeneration [5].
Bone tissue engineering benefits from Mesenchymal Stem Cells
(MSC) along with bone material (natural or synthetic) instead of
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scaffold which carries the stem cells into the defect and helps to
preserve the bone volume [4,5]. The MSCs, on the other hand, are
the vital components which are responsible for new bone forma-
tion [5]. These cells are known as a group of multi-potent, self-
renewing progenitor cells which are able to differentiate into all
types of cells with the mesenchymal origin, including osteoblasts,
chondroblasts and myoblasts [5,6]. They are easily obtainable from
adult bone marrow and some other tissues such as fat tissue and
periosteum [7]. Although their high proliferation and differentia-
tion potential could be effective in regeneration of bone defects,
several studies demonstrated just a moderate improvement of
new bone formation by using MSCs [7,8]. In these studies, a variety
of osteo-inductive techniques have been used to increase the rate,
quantity and quality of bone repair, including biochemical com-
pounds (growth factors, bone morphogenic proteins) and physical
stimulus (low level laser, ultrasonic waves) [5,9].
In the past decade, several studies have evaluated the effects of
Low Level Laser Therapy (LLLT) on bone regeneration [9–11]. It has
been showed that in vitro application of LLLT could lead to higher
activity of alkaline phosphatase enzyme, increased intra-cellular
calcium concentration and increased activity of osteoblasts leading
to a higher rate of new bone formation [12–14]. In addition, several
in vivo studies have revealed that LLLT promotes the rate and
amount of new bone formation in standardized bone defects and
also improves bone healing in artificial fractures [11,15,16].
However, there is little information about the in vivo effects of
using LLLT in conjunction with MSCs on bone healing. The aim of
this study was to evaluate the effect of LLLT alone and in conjunc-
tion with autologous MSCs on bone regeneration of calvarial
defects in rabbits.2. Materials and methods
2.1. Animals
Fifteen male New Zealand white rabbits aged between 8 and
12 months and with a mean weight of 3320 ± 370 g were used in
this study. The bone marrow sampling procedure commenced
1 week after adaptation. All animals were housed separately in
large, well-lit standard cages in an animal laboratory controlled
for temperature (21 C) and maintained with a daily photoperiod
of 12 h of light. Each animal had ad libitum access to food and
water. All experiments followed the guidelines of the Iran Animal
Care Committee and were approved by the AJA University of
Medical Science animal care committee, Ethical Approval No. 88/
12/12.
2.2. Bone marrow sampling
Intramuscular injection of 50 mg/kg ketamine hydrochloride
(100 mg/mL, Alfasan, Woerden-Holland) and 10 mg/kg xylazine
hydrochloride (20 mg/mL, Alfasan, Woerden-Holland) were used
for anesthetizing the rabbits. After shaving and disinfecting the
region, almost 3 mL of bone marrow were aspirated from the
humerus of the animals using the Jamshidi aspiration needle and
a 10 mL syringe containing 3000 U of heparin. All procedures were
carefully performed under sterile conditions to avoid bacterial
infection of the samples.
2.3. Mesenchymal stem cells preparation
The bone marrow aspirates were suspended in 5 mL Dulbecco’s
modified Eagle’s medium (DMEM, Gibco, Germany) supplemented
with 100 IU/mL penicillin (Sigma, USA), 100 IU/mL streptomycin(Sigma, USA) and 10% Fetal Bovine Serum (FBS). The cells were pla-
ted in 75 cm2 culture flasks at a density of 105 cells/mL in an atmo-
sphere of 5% CO2 and 37 C [17]. After 1 week, cells attached to the
bottom of the flasks were washed by phosphate buffered saline
(PBS – Gibco, USA) and culture medium was replaced with fresh
DMEM [17]. The flasks were incubated and medium replacement
took place twice per week until the cultures became confluent.
At 60–70% confluence, second passage cultures of MSCs were
washed with PBS and trypsinized with trypsin/EDTA (0.2%). MSCs
labeled with vital fluorescent dye (PKH26) 24 h before the surgical
procedure to track cells proliferation. The cells were then sus-
pended in collagen type I (Koken, Japan) at a density of 105 cells/
mL and loaded onto Bio-Oss scaffolds in preparation for surgery.
2.4. Bio-Oss resorbable scaffold
Bio-Oss was used in several studies as the scaffold for MSCs
[17–19]. Bio-Oss is a resorbable natural bone substitute usually
used for bone regeneration in the oral cavity [16]. It is originally
deproteinized bovine bone in particulate form with high intercon-
necting porosity which makes it suitable for angiogenesis and also
cell proliferation and migration [17–19]. It is integrated into the
natural modeling and remodeling procedures and the new bone
deposited directly on the Bio-Oss particles. These features make
Bio-Oss a reliable scaffold in tissue engineered bone regeneration.
2.5. Surgical procedure
Animals were intramuscularly anesthetized as described above.
After shaving and disinfecting the animals’ head, a full thickness
incision was made over the midline to expose the underlying pari-
etal bone. Four symmetric circular full thickness bone defects were
made through the calvaria using a trephine bur with an outer
diameter of 6 mm as described in previous studies [20] (Fig. 1).
These bone defects in each animal served as four different experi-
mental groups: control (C), laser (L), stem cells (SC) and combina-
tion of laser and stem cells (SCL). Scaffolds and MSCs were inserted
into the SC and SCL defects and the other two defects (C and L)
remained empty. The L and SCL defects received one treatment
of LLLT before closing the incision. Finally the periosteum and
the skin were tightly sutured in two different layers with an
absorbable 4-0 suture material (Vicryl, Ethicon, USA) to seal the
area and keep the scaffolds in their places. All the animals received
subcutaneous injection of enrofloxacin (5 mg/kg, Baytril, Bayer
Corp, USA) and tramadol hydrochloride (4 mg/kg, Tehran Chemie
Pharmaceutical Co, Tehran, Iran) for 5 days after the surgery. The
animals were sacrificed after 3 weeks by an overdose of sodium
pentobarbital.
2.6. Low level laser therapy
The laser therapy for L and SCL defects was initiated at the time
of surgery and then continued every other day for 3 weeks. A con-
tinuous emission mode Gallium–Aluminum–Arsenide (GaAlAs)
diode laser (THOR Photomedicine Ltd. UK) with a wavelength of
810 nm, power output of 200 mW, power density of 0.2 W/cm2,
spot size of 1 cm2, distance of 0.5 cm, period of 20 s and fluency
of 4 J/cm2 per session was utilized as the source of LLLT.
2.7. Histologic and histomorphometric evaluation
After 3 weeks, all the animals were sacrificed and the calvariae
were removed and fixed in 10% buffered formalin solution for
2 weeks. The specimens were soaked in 14% EDTA solution for
decalcification while their softening or calcification was controlled
frequently as they were to be cut by microtome device. After
Fig. 1. Photograph of four circular bone defects created with the diameter of 6 mm.
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thickness were prepared and then stained with hematoxilyne
and eosin. The specimens’ tissue was covered by a thin lamellar
glass and evaluated by a pathologist blinded to the defect treat-
ment modality using a light microscope with 40 magnification
(double-head light microscope, Nikon, Eclipse E-400, Japan).
Photomicrographs were taken from different areas of the defects
using a digital camera (Nikon Fuji HC-300 Nikon) and the percent-
age of new bone formation and remaining scaffold was calculated
using a computer assisted histomorphometric analysis system
(Iranian histomorphometric analysis software – IHMM-version 1)
[15]. The amount of inflammation was estimated for each sample,
considering the frequency of inflammatory cells in the high power
field (400), ranging from grade 1 to 5: 1, less than 30%; 2,
between 10% and 30%; 3, between 30% and 50%, 4, between 50%
and 70% and 5, more than 70% cellular infiltration. Fluorescence
illumination (Fig. 2) was used in some sections to verify the sur-
vival and proliferation of PKH26-labeled MSCs on the grafts after
staining with 5 lg/mL DAPI solution (Sigma, USA).
2.8. Sample size and statistical analysis
The sample size in each group was defined considering stan-
dardized effect size (corresponding mean and standard deviations),
significance level of 0.05 and 90% power, in addition to possibility
of 20% drop off of the samples during the study.
The means and standard deviations of new bone region,
remaining scaffold and inflammation were calculated for each
group of defects. Considering normal distribution of values, one
way ANOVA test and then Scheffe post hoc multiple comparison
test were used to compare the data. p values less than 0.05 were
considered statistically significant in each case.3. Results
3.1. Clinical observation
Twelve rabbits recovered normally after the surgical procedure
and three animals died during the recovery period after anesthesia.
The surgical region repaired normally and no complications were
observed among the remaining 12 rabbits. The following reported
results are based on histological evaluation of 48 bone defects on
12 rabbits. The average weight of animals at the time of sacrifice
was 3750 ± 530 g.3.2. Histological analysis
Extensive proliferation of MSCs was indicated by increased flu-
orescence of experimental group samples (Fig. 2). The percentage
of new bone formation, remaining Bio-Oss and amount of inflam-
mation at 3 weeks after the surgery are listed in Table 1.
Statistical analysis indicated a significant difference in level of
bone formation among the defect groups (p < 0.001). Group L
showed the highest level of new bone formation which was statis-
tically significantly higher than the other three groups (p < 0.05).
Compared to group C, groups S and SCL indicated a higher level
of new bone formation but, the difference was not statistically sig-
nificant (p > 0.05). In addition there was no statistically significant
difference between groups S and SCL with respect to the level of
bone formation (p > 0.05) (Table 1).
Bio-Oss was used as the scaffold only in groups S and SCL. After
3 weeks, there was no statistically significant difference between
these two groups regarding the amount of remaining Bio-Oss
(p > 0.05).
Histological evaluation demonstrated different levels of chronic
inflammation in each group of defects. Groups SC and SCL demon-
strated a statistically significant higher level of inflammation com-
pared to the other two groups (L and C) (p < 0.05). However, the
differences between groups SC and SCL and between groups C
and L were not statistically significant (p > 0.05) (Fig. 3).4. Discussion
The present study was performed to clarify the combined and
individual contributions of LLLT and bone marrow derived MSCs
to bone regeneration of calvarial defects in rabbits. Although sev-
eral studies have reported on the isolated effects of LLLT or MSC
on bone regeneration [6–9,15], there is just one other study assess-
ing the synergistic effect in vivo [11].
Male adult New Zealand white rabbits were used as the animal
model in this study because of their appropriate size which
allowed induction of four 6 mm circular defects in each animal’s
calvarium. In this study, the bone defects were smaller than the
Critical Size Defect (CSD) in rabbits. CSD is known as the smallest
defect on a bone of specific species which will not spontaneously
repair during its life time [21]. Although a range of 10–15 mm
has been considered as the critical size defect of rabbits’ calvaria,
some studies have concluded that it is not possible to define the
exact dimension of CSD [21,22]. Furthermore, it has been sug-
gested that the term ‘‘critical size defect” should no longer be used
because the repair potential of bony margin was shown to be con-
stant despite defect size [22]. Therefore, we used four 6 mm circu-
lar defects to investigate different methods of bone regeneration in
a relatively short period of time. Several studies reported signifi-
cant amounts of new bone formation even after 2 weeks, so we
chose 3 weeks of follow up to compare the effect of interventions
on the early stages of healing process [7,23].
Histological assessment in this study demonstrated higher level
of inflammation in SC and SCL groups comparing to L and C groups.
Although there was no foreign body reaction or severe inflamma-
tion in neither of groups, the higher level of chronic inflammation
in SC and SCL groups could be due to Bio-Oss. In spite of the fact
that Bio-Oss is frequently reported as a biocompatible and osteo-
conductive biomaterial, it may be the reason of higher inflamma-
tion in the early stages of bone healing in this study [17,18]. In
addition, slight movements of Bio-Oss particles in full-thickness
bone defects may be in part responsible for more physical irritation
and inflammation.
Histomorphometric assessment indicated that group L had the
highest level of new bone formation (L = 27.8%). Our results are
Fig. 3. Histomorphometric analysis of 4 calvarial defects after 3 weeks. New bone form
material (Bio-Oss). (A) Control group, 11.9% of new bone formation. (B) Laser group, 28% o
remaining Bio-Oss. (D) Stem cell and Laser group, 17% of new bone formation and 13%
Fig. 2. Frequency and distribution of fluorescence-labeled MSCs in bone treatments of experimental group. MSCs were labeled using PKH26 in red (A) while the nuclei were
stained with fluorescence-labeled DAPI indicated in blue (B). Merging A and B produced (C). (For interpretation of the references to color in this figure legend, the reader is
referred to the web version of this article.)
Table 1
Mean ± SD values of the histological variables as percentages within surgically
induced defects.






Control (C) 10.78 ± 7.05 0.0 ± 0.0 18.2 ± 3.5
Laser (L) 27.80 ± 10.90a 0.0 ± 0.0 16.9 ± 4.7
Stem cells (SC) 15.23 ± 7.17 27.14 ± 5.35 59.8 ± 8.6b
Laser and stem
cells (SCL)
16.12 ± 6.25 29.41 ± 6.46 55.3 ± 6.2b
a Statistically significant difference from all other defect groups.
b Statistically significant difference from the control and laser groups.
R. Fekrazad et al. / Journal of Photochemistry and Photobiology B: Biology 151 (2015) 180–185 183similar to those of Khadra et al., who used LLLT to enhance bone
regeneration in calvarial bone defects of rabbits [9]. They
employed a diode laser with a wavelength of 830 nm, power out-
put of 75 mW and total energy density of 23 J/cm2, to treat
2.7 mm bone defects immediately after surgery and 6 days there-
after. Their results revealed that the experimental group had sig-
nificantly higher levels of bone formation, angiogenesis, and
fibroblast proliferation after 2 and 4 weeks. Furthermore, they
showed increased levels of calcium, phosphate and protein in the
laser group. In another study by Pretel et al., a single dose of
LLLT with wavelength of 780 nm and power output of 35 mW led
to significantly improved bone regeneration and lower level ofation is indicated by white arrowheads. Black arrowheads indicate remaining graft
f new bone formation. (C) Stem cell group, 13.6% of new bone formation and 33% of
of remaining Bio-Oss.
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Interestingly, they found no difference between groups after
60 days. Considering all similar studies, it seems that LLLT could
be significantly effective in improving rate of bone regeneration
in animals. However, this result is in contrast to findings of Choi
et al., who found no statistical difference between bone regenera-
tion of LLLT group and Acellular Dermal Matrix (ADM) group in
4 mm calvarial defects of mice [11].
Although histomorphometric evaluation of the samples after
3 weeks showed higher levels of new bone formation for groups
SC and SCL (SC = 15.23%, SCL = 16.12%) compared to the control
group (C = 10.78%), the difference was statistically insignificant.
This indicates that using bone marrow derived MSCs and Bio-Oss
could not significantly improve bone regeneration during a 3 week
period of time in calvarial defects of rabbits. However, it led to rel-
atively higher amounts of bone formation after just 21 days and if
the samples were assessed for a longer period of time, it might
have made a bigger difference. Similar results were obtained by
Yun et al., who investigated synergistic effects of BMMSCs and
Platelet-Rich Plasma (PRP) on bone regeneration [24]. They used
calvarial defects of 6 mm diameter and hydroxyapatite as the scaf-
fold for MSCs. They found no significant difference between groups
after 2–4 weeks and only after 8 weeks the group with MCSs and
PRP showed a higher amount of new bone formation. Another
study conducted by Behnia et al., using 8 mm calvarial defects
and Bio-Oss as the scaffold, also reported no significant difference
between MSCs group and control group after 6 weeks [25].
However, they reported significantly higher bone formation in
the experimental group after 12 weeks. Additional studies that also
reported similar short term results in regards to application of
MSCs in rabbits, indicate that using MSCs in regards to improving
bone regeneration requires more than 3 weeks to be efficient [24].
However, in a recent experimental study Choi et al. reported signif-
icantly higher amount of bone formation just after 2 weeks by
using adipose-derived mesenchymal stem cell seeded ADM on
4 mm calvarial defects of mice [11]. The probable explanation
may include environmental stress (e.g. changes in temperature,
available nutrition, inflammation of the region, etc.) caused by
transferring MSCs from enriched media into the animal body or
even the physical manipulation of cells during the surgery which
affected their proliferation rate and function. Furthermore, this
delayed bone formation could be due to the time that MSCs need
to differentiate into functional osteoblasts. However, after a short
period of time, MSCs contribute to new bone formation and accel-
erate the healing process [7,24,25]. High levels of inflammation in
groups SC and SCL could be another contributing factor to reduced
bone formation. The increased inflammation may be attributed to
an immunologic response to the scaffold or even the physical irri-
tation of the region.
According to the results of the present study, using low level
laser therapy along with MSCs for a period of 3 weeks had little
advantage over implementation of MSCs alone, considering the
amount of new bone formation. These results are in contrast
to the previously published data from Choi et al., who reported
a significant positive effect of using HeNe laser in conjunction
with MSCs on bone generation of mice [11]. There are also some
in vitro studies which presented positive effects of LLL in cell
cultures, including increased proliferation and differentiation of
stem cells, higher amount of growth factor secretion and
increased levels of calcium and alkaline phosphatase activity
[26,27].
In addition to the local effects of LLLT, there are some reports on
the systematic effects of LLLT as well [28]. Although these systemic
effects are not as strong as the local ones, it could be considered as
a limitation of the present study. So, further studies could be
accomplished by selecting different defects in separate animals.5. Conclusion
Using LLLT in the experimental conditions described for a per-
iod of 3 weeks could be significantly effective in improving bone
regeneration. However, applying MSCs alone or in addition to
LLLT may not make a significant difference in bone formation over
a short period of time in rabbits. This study conclusively indicated
no synergistic effect of MSC and LLLT in conditions described.Conflict of interest
No competing financial interests exist.
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